GlassScriptPhysician profile
Jayaseelan Ambrose
NPI 1437155363
$33,065.55
in general payments reported to CMS, 2019-2025
37 companies · $4,250 in 2025
The $4,250 reported for 2025 was more than what 81% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,229 · 2020: $1,343 · 2021: $1,756 · 2022: $17K · 2023: $5,124 · 2024: $1,193 · 2025: $4,250.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,264 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $3,300 · Travel and Lodging: $3,003.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,264.26 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $3,300.00 |
| Travel and Lodging | $3,003.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $14,956.89 | 2019-2024 | Xarelto |
| Abbott Laboratories | $4,679.09 | 2019-2025 | Aveir, Assurity, Gallant |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $4,465.75 | 2019-2025 | Lifevest |
| Boston Scientific Corporation | $2,375.52 | 2020-2025 | Watchman Flx, Watchman Access System |
| Abiomed | $925.09 | 2021-2025 | Impella |
| E.R. Squibb & Sons, L.L.C. | $852.54 | 2019-2024 | Eliquis, Camzyos |
| Novartis Pharmaceuticals Corporation | $735.14 | 2019-2024 | |
| Actelion Pharmaceuticals US, INC. | $637.69 | 2019-2023 | Opsumit, Uptravi |
| Amgen INC. | $534.12 | 2019-2024 | Repatha |
| Pfizer INC. | $450.16 | 2019-2025 | |
| Medtronic Vascular, INC. | $347.43 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $325.31 | 2019-2024 | Farxiga |
| Boehringer Ingelheim Pharmaceuticals, INC. | $253.21 | 2019-2024 | Jardiance |
| Venclose INC. | $184.00 | 2020 | |
| Merck Sharp & Dohme LLC | $173.57 | 2022-2024 | Verquvo |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $171.05 | 2020-2022 | |
| Sanofi-Aventis U.S. LLC | $118.53 | 2019-2024 | |
| Chiesi USA, INC. | $100.57 | 2020-2022 | |
| Kiniksa Pharmaceuticals, LTD. | $90.19 | 2023 | Arcalyst |
| Kiniksa Pharmaceuticals International, Plc | $67.31 | 2024 | Arcalyst |
| Bard Peripheral Vascular, INC. | $61.32 | 2020-2021 | |
| Lexicon Pharmaceuticals, INC. | $60.51 | 2023-2024 | Inpefa |
| Terumo Medical Corporation | $59.42 | 2019-2025 | Metacross Otw, Glidesheath Slender, Glidewire |
| Cardiovascular Systems INC. | $58.61 | 2019-2023 | Diamondback Coronary |
| Impulse Dynamics (USA) INC. | $50.52 | 2022-2023 | Optimizer |
| Kestra Medical Technology Services, INC. | $43.14 | 2022 | |
| Portola Pharmaceuticals, LLC | $35.63 | 2020 | |
| Janssen Scientific Affairs, LLC | $35.26 | 2022 | |
| Medtronic, INC. | $33.21 | 2021 | |
| Acist Medical Systems, INC. | $32.92 | 2023-2024 | |
| Tactile Systems Technology INC | $29.35 | 2020-2023 | Entre Plus, Flexitouch Plus |
| Genzyme Corporation | $27.27 | 2022 | |
| Lantheus Medical Imaging, INC. | $21.81 | 2024 | |
| Shockwave Medical, INC | $21.53 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Alnylam Pharmaceuticals INC. | $18.91 | 2021 | |
| Scpharmaceuticals INC. | $16.94 | 2023 | |
| Ge Healthcare | $16.04 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jayaseelan Ambrose listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.